Mechanism of flt3 ligand expression in bone marrow failure: Translocation from intracellular stores to the surface of T lymphocytes after chemotherapy-induced suppression of hematopoiesis

Blood

Volumn 93, Issue 8, 1999, Pages 2595-2604

  Chklovskaia, Elena ^b   Jansen, Wendy ^b   Nissen, Catherine ^b   Lyman, Stewart D ^b   Rahner, Christoph ^b   Landmann, Lukas ^b   Wodnar Filipowicz, Aleksandra ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE MARROW CELL; BONE MARROW DEPRESSION; CELL PROLIFERATION; CHROMOSOME TRANSLOCATION; COMPLEX FORMATION; DENDRITIC CELL; HEMATOPOIESIS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LIGAND BINDING; MEMBRANE BINDING; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR UPREGULATION; T LYMPHOCYTE ACTIVATION;

EID: 0033561443     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v93.8.2595     Document Type: Article

References (41)

1. Ogawa M: Differentiation and proliferation of hematopoietic stem cells. Blood 81:2844, 1993
2. Morrison SJ, Uchida N, Weissman IL: The biology of hematopoietic stem cells. Annu Rev Cell Dev Biol 11:35, 1995
3. Lyman SD, James L, Vanden BT, de Vries P, Brasel K, Gliniak B, Hollingsworth LT, Picha KS, McKenna HJ, Splett RR, Fletcher FF, Maraskovsky E, Farrach F, Foxworthe D, Williams DE, Beckmann MP: Molecular cloning of a ligand for the flt3/flk-2 tyrosine kinase receptor: A proliferate factor for primitive hematopoietic cells. Cell 75:1157, 1993
4. Hannum C, Culpepper J, Campbell D, McClanahan T, Zurawski S, Bazan JF, Kastelein R, Hudak S, Wagner J, Mattson J, Luh J, Duda G, Martina N, Peterson D, Menon S, Shanafelt A, Muench M, Kelner G, Namikawa R, Rennick D, Roncarolo M-G, Zlotnik A, Rosnet O, Dubreuil P, Birnbaum D, Lee F: Ligand for FLT3/FLK2 receptor tyrosine kinase regulates growth of haematopoietic stem cells and is encoded by variant RNAs. Nature 368:643, 1994
5. Ullrich A, Schlessinger Y: Signal transduction by receptors with tyrosine kinase activity. Cell 61:203, 1990
6. Small D, Levenstein M, Kim E, Carow C, Amin S, Rockwell P, Witte L, Burrow C, Ratajczak MZ, Gewirtz AM, Civin C: STK-1, the human homolog of Flk-2/Flt-3, is selectively expressed in CD34+ human bone marrow cells and is involved in the proliferation of early progenitor/stem cells. Proc Natl Acad Sci USA 91:459, 1994
7. Lyman S, Jacobsen S: c-kit ligand and Flt3 ligand: Stem/ progenitor cell factors with overlaping yet distinct activities. Blood 91:1101, 1998
8. Strobl H, Bello-Femandez C, Riedl E, Pickl WF, Majdic O, Lyman SD, Knapp W: Flt3 ligand in cooperation with transforming growth factor-b1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 90:1425, 1997
9. Maraskovsky E, Brasel K, Teepe M, Roux ER, Lyman SD, Shortman K, McKenna HJ: Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: Multiple dendritic cell subpopulations identified. J Exp Med 184:1953, 1996
10. Lynch DH, Andreasen A, Maraskovsky E, Whitmore J, Miller RE, Schuh JCL: Flt3 ligand induces tumor regression and antitumor immune responses in vivo. Nat Med 3:625, 1997
11. Lyman SD, James L, Johnson L, Brasel K, de Vries P, Escobar SS, Downey H, Splett RR, Beckmann MP, McKenna HJ: Cloning of the human homologue of the murine flt3 ligand: A growth factor for early hematopoietic progenitor cells. Blood 83:2795, 1994
12. Lyman SD, Stocking K, Davison B, Fletcher F, Johnson L, Escobar S: Structural analysis of human and murine flt3 ligand genomic loci. Oncogene 11:1165, 1995
13. Lyman SD, Seaberg M, Hanna R, Zappone J, Brasel K, Abkowitz JL, Prchal J, Schultz J, Shahidi NT: Flt3 ligand plasma/serum levels are low in normal individuals and are highly elevated in patients with Fanconi anemia and acquired aplastic anemias. Blood 86:4091, 1995
14. Wodnar-Filipowicz A, Lyman S, Gratwohl A, Tichelli A, Speck B, Nissen C: Flt3 ligand level reflects hematopoietic progenitor cell function in aplastic anemia and chemotherapy-induced bone marrow aplasia. Blood 88:4493, 1996
15. Mamiya S, Itoh T, Miura AB: Acquired pure red cell aplasia in Japan. Eur J Haematol 59:199, 1997
16. Ballmaier M, Schulze H, Strauss G, Charkaoui K, Wittner N, Lynen S, Wolters S, Bogenberger J, Welte K: Thrombopoietin in patients with congenital thrombocytopenia and absent radii: Elevated serum levels, normal receptor expression, but defective reactivity to thrombopoietin. Blood 90:612, 1997
17. Mempel K, Pietsch T, Menzel T, Zeidler C, Welte K: Increased serum levels of granulocyte colony-stimulating factor in patients with severe congenital neutropenia. Blood 77:1919, 1991
18. Wodnar-Filipowicz A, Yancik S, Moser Y, dalle Carbonare V, Gratwohl A, Tichelli A, Speck B, Nissen C: Levels of soluble stem cell factor in serum of patients with aplastic anemia. Blood 81:3259, 1993
19. Testa U, Martucci R, Rutella S, Scambia G, Sica S, Benedetti Panici P, Pierelli L, Menichella G, Leone G, Mancuso S, Peschle C: Autologous stem cell transplantation: Release of early and late acting growth factors relates with hematopoietic ablation and recovery. Blood 84:3532, 1994
20. Prussin C, Metcalfe DD: Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies. J Immunol Methods 188:117, 1995
21. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
22. Lyman SD, James L, Escobar S, Downey H, de Vries P, Brasel K, Stocking K, Beckman MP, Copeland NG, Cleveland LS, Jenkins NA, Belmont JW, Davison BL: Identification of soluble and membrane-bound isoforms of the murine flt3 ligand generated by alternative splicing of mRNAs. Oncogene 10:149, 1995
23. Nakajima-Ijima S, Hamada H, Reddy P, Kakunaga T: Molecular structure of the human cytoplasmic beta-actin gene: Interspecies homology of sequences in the introns. Proc Natl Acad Sci USA 82:6133, 1985
24. Alonso S, Minty A, Bourlet Y, Buckingham M: Comparison of three actin-coding sequences in the mouse: Evolutionary relationships between the acting genes of warm-blooded vertebrates. J Mol Evol 23:11, 1986
25. McClanahan T, Culpepper J, Campbell D, Wagner J, Franz-Bacon K, Mattson J, Tsai S, Luh J, Guimaraes J, Mattei M-G, Rosnet O, Birnbaum D, Hannum CH: Biochemical and genetic characterisation of multiple splice variants of the flt3 ligand. Blood 88:3371, 1996
26. Farquhar MG, Hauri H-P: Protein sorting and vesicular traffic in the Golgi apparatus, in Berger EG, Roth J (eds): The Golgi Apparatus. Basel, Switzerland, Birkhäuser, 1997, p 63
27. Rothman JE, Wieland FT: Protein sorting by transport vesicles. Science 272:227, 1996
28. Goldberg MA, Dunning SP, Bunn HF: Regulation of the erythropoietin gene: Evidence that the oxygen sensor is a heme protein. Science 242:1412, 1988
29. Kronke M, Leonard W, Depper J, Greene W: Sequential expression of genes involved in human T lymphocyte growth and differentiation. J Exp Med 161:1593, 1985
30. Ernst TJ, Ritchie AR, Demetri GD, Griffin JD: Regulation of granulocyte- and monocyte-colony stimulating factor mRNA levels in human blood monocytes is mediated primarily at a post-transcriptional level. J Biol Chem 264:5700, 1989
31. Wodnar-Filipowicz A, Moroni C: Regulation of interleukin 3 mRNA expression in mast cells occurs at the posttranscriptional level and is mediated by calcium ions. Proc Natl Acad Sci USA 87:777, 1990
32. Jason J, Lamed J: Single-cell cytokine profiles in normal humans: Comparison of flow cytometric reagents and stimulation protocols. J Immunol Methods 207:13, 1997
33. Hanamura T, Motoyoshi K, Yoshida K, Saito M, Mijura T, Kawashima T, Nishida M, Takaku F: Quantitation and identification of human monocytic colony-stimulating factor in human serum by enzyme-linked immunosorbent assay. Blood 72:886, 1988
34. Langley KE, Bennett LG, Wypych J, Yancik SA, Liu XD, Westcott KR, G. CD, Smith KA, Zsebo KM: Soluble stem cell factor in human serum. Blood 81:656, 1993
35. Kiener PA, Davis PM, Rankin BM, Klabanoff SJ, Ledbetter JA, Startling GC, Liles WC: Human monocytic cells contain high levels of intracellular Fas ligand. J Immunol 159:1594, 1997
36. Henn V, Slupsky J, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, Kroczek R: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391:591, 1998
37. Martinez-Lorenzo MJ, Alava MA, Anel A, Oineiro A, Naval J: Release of preformed Fas ligand in soluble form is the major factor for activation-induced death of Jurkat T cells. Immunology 89:511, 1996
38. Black RA, Rauch CT, Kozlosky CJ, Peschon JJ, Slack JL, Wolfson MF, Castner BJ, Stocking KL, Reddy P, Srinivasan S, Nelson N, Boiani N, Schooley KA, Gerhart M, Davis R, Fitzner JN, Johnson RS, Paxton RJ, March CJ, Cerretti DP: A metalloproteinase disintegrin that releases tumor-necrosis factor-α from cells. Nature 385:729, 1997
39. Moss ML, Jin C, Milla ME, Bickett DM, Burkhart W, Carter HL, Chen WJ, Clay WC, Didsbury JR, Hassler D, Hoffman CR, Kost TA, Lambert MH, Leesnitzer MA, McCauley P, McGeehan G, Mitchell J, Moyer M, Pahel G, Rocque W, Overton LK, Schoenen F, Seaton T, Su JL, Becherer JD: Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature 385:733, 1997
40. Toksoz D, Zsebo KM, Smith KA, Hu S, Brankow D, Suggs SV, Martin FH, Williams DA: Support of human hematopoiesis in long-term bone marrow cultures by murine stromal cells selectively expressing the membrane-bound and secreted forms of the human homolog of the steel gene product, stem cell factor. Proc Natl Acad Sci USA 89:7350, 1992
41. Flanagan JG, Chan DC, Leder P: Transmembrane form of the kit ligand growth factor is determined by alternative splicing and is missing in the Sld mutant. Cell 64:1025, 1991